Literature DB >> 23653393

A rapid membrane potential assay to monitor CFTR function and inhibition.

Rangan Maitra1, Perumal Sivashanmugam, Keith Warner.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) protein is an important regulator of ion transport and fluid secretion in humans. Mutations to CFTR cause cystic fibrosis, which is a common recessive genetic disorder in Caucasians. Involvement of CFTR has been noted in other important diseases, such as secretory diarrhea and polycystic kidney disease. The assays to monitor CFTR function that have been described to date either are complicated or require specialized instrumentation and training for execution. In this report, we describe a rapid FlexStation-based membrane potential assay to monitor CFTR function. In this assay, agonist-mediated activation of CFTR results in membrane depolarization that can be monitored using a fluorescent membrane potential probe. Availability of a simple mix-and-read assay to monitor the function of this important protein might accelerate the discovery of CFTR ligands to study a variety of conditions.

Entities:  

Keywords:  CFTR; assay; cystic fibrosis; ion channel; membrane potential

Mesh:

Substances:

Year:  2013        PMID: 23653393     DOI: 10.1177/1087057113488420

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  13 in total

1.  Triangulating variation in the population to define mechanisms for precision management of genetic disease.

Authors:  Chao Wang; Frédéric Anglès; William E Balch
Journal:  Structure       Date:  2022-06-16       Impact factor: 5.871

2.  ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter.

Authors:  Puay-Wah Phuan; Guido Veit; Joseph-Anthony Tan; Ariel Roldan; Walter E Finkbeiner; Peter M Haggie; Gergely L Lukacs; Alan S Verkman
Journal:  SLAS Discov       Date:  2018-03-13       Impact factor: 3.341

3.  Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.

Authors:  Humaira Adnan; Zhenbo Zhang; Hyun-Joo Park; Chetankumar Tailor; Clare Che; Mustafa Kamani; George Spitalny; Beth Binnington; Clifford Lingwood
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

4.  Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells.

Authors:  Erika N Sutanto; Amelia Scaffidi; Luke W Garratt; Kevin Looi; Clara J Foo; Michela A Tessari; Richard A Janssen; David F Fischer; Stephen M Stick; Anthony Kicic
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

5.  Orkambi® and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue.

Authors:  Steven V Molinski; Saumel Ahmadi; Wan Ip; Hong Ouyang; Adriana Villella; John P Miller; Po-Shun Lee; Kethika Kulleperuma; Kai Du; Michelle Di Paola; Paul Dw Eckford; Onofrio Laselva; Ling Jun Huan; Leigh Wellhauser; Ellen Li; Peter N Ray; Régis Pomès; Theo J Moraes; Tanja Gonska; Felix Ratjen; Christine E Bear
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

6.  Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia.

Authors:  Saumel Ahmadi; Zoltan Bozoky; Michelle Di Paola; Sunny Xia; Canhui Li; Amy P Wong; Leigh Wellhauser; Steven V Molinski; Wan Ip; Hong Ouyang; Julie Avolio; Julie D Forman-Kay; Felix Ratjen; Jeremy A Hirota; Johanna Rommens; Janet Rossant; Tanja Gonska; Theo J Moraes; Christine E Bear
Journal:  NPJ Genom Med       Date:  2017-04-14       Impact factor: 8.617

7.  Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function.

Authors:  Arnaud Billet; Lionel Froux; John W Hanrahan; Frederic Becq
Journal:  Front Pharmacol       Date:  2017-04-07       Impact factor: 5.810

8.  Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators.

Authors:  Onofrio Laselva; Giovanni Marzaro; Christian Vaccarin; Ilaria Lampronti; Anna Tamanini; Giuseppe Lippi; Roberto Gambari; Giulio Cabrini; Christine E Bear; Adriana Chilin; Maria C Dechecchi
Journal:  Front Pharmacol       Date:  2018-07-04       Impact factor: 5.810

9.  Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases.

Authors:  Faisa Omar; Jane E Findlay; Gemma Carfray; Robert W Allcock; Zhong Jiang; Caitlin Moore; Amy L Muir; Morgane Lannoy; Bracy A Fertig; Deborah Mai; Jonathan P Day; Graeme Bolger; George S Baillie; Erik Schwiebert; Enno Klussmann; Nigel J Pyne; Albert C M Ong; Keith Bowers; Julia M Adam; David R Adams; Miles D Houslay; David J P Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205

Review 10.  Strategies for cystic fibrosis transmembrane conductance regulator inhibition: from molecular mechanisms to treatment for secretory diarrhoeas.

Authors:  Hugo R de Jonge; Maria C Ardelean; Marcel J C Bijvelds; Paola Vergani
Journal:  FEBS Lett       Date:  2020-11-16       Impact factor: 3.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.